Acting for the Australian Government in four heavily fought and ground-breaking claims (valued together at more than A$750 million) brought by the Government against global pharmaceutical companies, arising from delays in competition for blockbuster medicines in the Australian market.
The content of this publication is for reference purposes only. It is current at the date of publication. This content does not constitute legal advice and should not be relied upon as such. Legal advice about your specific circumstances should always be obtained before taking any action based on this publication.